Antibody-targeted thrombolytic agents
- PMID: 2204740
- DOI: 10.1253/jcj.54.345
Antibody-targeted thrombolytic agents
Abstract
Plasminogen activator therapy for acute myocardial infarction has become standard medical practice. Bleeding complications, however, limit the utility of the currently available agents. This article reviews how the tools of immunology, molecular biology and protein engineering are being used to develop safer and more effective plasminogen activators.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical